Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 24 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (10)
P 2 (4)
P 3 (1)

Trial Status

Completed10
Unknown6
Recruiting4
Active Not Recruiting2
Withdrawn1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (24)

Showing 20 of 20 trials
NCT04084249Not ApplicableActive Not Recruiting

ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

NCT07222800Phase 3Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

NCT07351071Not ApplicableRecruiting

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

NCT04369053Completed

Prevention of Colorectal Cancer Through Multiomics Blood Testing

NCT07037693CompletedPrimary

Prediction of Postoperative Outcomes After Rectal Resection by the Comprehensive Complication Index (CCI)

NCT05551052Active Not Recruiting

CRC Detection Reliable Assessment With Blood

NCT05782010Not ApplicableRecruiting

SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids

NCT06325982Not ApplicableRecruiting

Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury

NCT03559543Phase 2Completed

Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma

NCT06048146Not ApplicableEnrolling By Invitation

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

NCT04080843Phase 2Completed

Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients

NCT05322486Unknown

Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases

NCT03633539Not ApplicableWithdrawn

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

NCT04887818Phase 2Unknown

Diltiazem Ointment With Lidocaine vs. Nifedipine Ointment With Lidocaine Ointment for Treatment of Chronic Anal Fissure

NCT04621695Not ApplicableUnknown

Comparison of Rubber Band Ligation and Haemorrhoidectomy in Patients With Symptomatic Haemorrhoids Grade III

NCT01816607CompletedPrimary

Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness

NCT02005965Unknown

Low Rectal Cancer Study (MERCURY II)

NCT01037049Phase 2Unknown

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

NCT01995942Unknown

Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial

NCT03072472Not ApplicableCompleted

BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities

Scroll to load more

Research Network

Activity Timeline